Vontobel Holding’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $434K | Buy |
7,901
+3,202
| +68% | +$176K | ﹤0.01% | 832 |
|
|
2025
Q1 | $332K | Sell |
4,699
-758
| -14% | -$53.6K | ﹤0.01% | 890 |
|
|
2024
Q4 | $359K | Sell |
5,457
-593
| -10% | -$39K | ﹤0.01% | 876 |
|
|
2024
Q3 | $425K | Buy |
6,050
+2,553
| +73% | +$179K | ﹤0.01% | 830 |
|
|
2024
Q2 | $288K | Sell |
3,497
-450
| -11% | -$37K | ﹤0.01% | 900 |
|
|
2024
Q1 | $345K | Sell |
3,947
-116
| -3% | -$10.1K | ﹤0.01% | 871 |
|
|
2023
Q4 | $392K | Sell |
4,063
-1,005
| -20% | -$96.9K | ﹤0.01% | 859 |
|
|
2023
Q3 | $448K | Sell |
5,068
-1,915
| -27% | -$169K | ﹤0.01% | 802 |
|
|
2023
Q2 | $605K | Buy |
6,983
+1,065
| +18% | +$92.3K | 0.01% | 742 |
|
|
2023
Q1 | $575K | Buy |
5,918
+379
| +7% | +$36.9K | 0.01% | 742 |
|
|
2022
Q4 | $564K | Buy |
5,539
+623
| +13% | +$63.4K | 0.01% | 725 |
|
|
2022
Q3 | $418K | Sell |
4,916
-1,561
| -24% | -$133K | ﹤0.01% | 766 |
|
|
2022
Q2 | $544K | Sell |
6,477
-754
| -10% | -$63.3K | 0.01% | 696 |
|
|
2022
Q1 | $563K | Sell |
7,231
-1,076
| -13% | -$83.8K | ﹤0.01% | 758 |
|
|
2021
Q4 | $739K | Buy |
8,307
+746
| +10% | +$66.4K | 0.01% | 708 |
|
|
2021
Q3 | $584K | Sell |
7,561
-179
| -2% | -$13.8K | 0.01% | 747 |
|
|
2021
Q2 | $646K | Buy |
7,740
+1,083
| +16% | +$90.4K | 0.01% | 697 |
|
|
2021
Q1 | $503K | Sell |
6,657
-1,263
| -16% | -$95.4K | ﹤0.01% | 672 |
|
|
2020
Q4 | $684K | Buy |
+7,920
| New | +$684K | ﹤0.01% | 552 |
|